HK1113364A1 - Indoline compound and process for producing the same - Google Patents

Indoline compound and process for producing the same

Info

Publication number
HK1113364A1
HK1113364A1 HK08103492.9A HK08103492A HK1113364A1 HK 1113364 A1 HK1113364 A1 HK 1113364A1 HK 08103492 A HK08103492 A HK 08103492A HK 1113364 A1 HK1113364 A1 HK 1113364A1
Authority
HK
Hong Kong
Prior art keywords
propyl
same
phenoxy
dihydro
producing
Prior art date
Application number
HK08103492.9A
Other languages
English (en)
Inventor
Toshiaki Yamaguchi
Ikuo Tsuchiya
Ken Kikuchi
Takashi Yanagi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of HK1113364A1 publication Critical patent/HK1113364A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK08103492.9A 2004-10-27 2008-03-28 Indoline compound and process for producing the same HK1113364A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004313040 2004-10-27
PCT/JP2005/019478 WO2006046499A1 (ja) 2004-10-27 2005-10-24 インドリン化合物およびその製造方法

Publications (1)

Publication Number Publication Date
HK1113364A1 true HK1113364A1 (en) 2008-10-03

Family

ID=36227738

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08103492.9A HK1113364A1 (en) 2004-10-27 2008-03-28 Indoline compound and process for producing the same

Country Status (18)

Country Link
US (1) US7834193B2 (ko)
EP (1) EP1806340B1 (ko)
JP (1) JP5049013B2 (ko)
KR (1) KR101249865B1 (ko)
CN (1) CN101048376B (ko)
AT (1) ATE508113T1 (ko)
AU (1) AU2005298078B2 (ko)
BR (1) BRPI0517515B8 (ko)
CA (1) CA2583660C (ko)
DE (1) DE602005027881D1 (ko)
ES (1) ES2362788T3 (ko)
HK (1) HK1113364A1 (ko)
IL (1) IL182642A (ko)
MX (1) MX2007005126A (ko)
RU (1) RU2379289C2 (ko)
TW (1) TW200621709A (ko)
WO (1) WO2006046499A1 (ko)
ZA (1) ZA200703996B (ko)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78854C2 (en) * 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
US8013007B2 (en) 2007-02-26 2011-09-06 Concert Pharmaceuticals, Inc. Alpha 1A-adrenoceptor antagonists
US20080242717A1 (en) * 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia
CN101585798B (zh) * 2008-05-20 2011-06-15 浙江华海药业股份有限公司 光学活性化合物1-(3-苯甲酰氧基丙基)-5-(2-(1-苯基乙基胺)丙基)-7-氰基吲哚啉及其制备方法和用途
CN101993405B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 吲哚啉衍生物、及其制备方法和用途
CN101993407B (zh) * 2009-08-27 2014-01-29 浙江华海药业股份有限公司 用于制备西洛多辛的吲哚啉化合物及其制备方法
CN101993406B (zh) * 2009-08-27 2014-01-15 浙江华海药业股份有限公司 光学活性的吲哚啉化合物及其制备方法
EP2475634B1 (en) * 2009-09-12 2017-05-24 Sandoz AG Process for the preparation of indoline derivatives and their intermediates thereof
CN101768056B (zh) * 2010-01-19 2013-10-16 扬子江药业集团有限公司 一种取代的苯基甲基醚的制备方法
WO2011101864A1 (en) 2010-02-17 2011-08-25 Panacea Biotec Ltd Novel process for the synthesis of phenoxyethyl derivatives
WO2011124704A1 (en) 2010-04-09 2011-10-13 Ratiopharm Gmbh Process for preparing an intermediate for silodosin
CN102311319A (zh) * 2010-07-05 2012-01-11 浙江华海药业股份有限公司 一种制备2-(2,2,2-三氟乙基)苯甲醚的方法
WO2012014186A1 (en) * 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Process for the preparation of silodosin and its novel intermediates
CN102229557B (zh) * 2010-08-05 2013-03-27 南京海纳医药科技有限公司 西洛多辛的半水合物晶体、制备方法和包含它的药物组合物
CN102229558B (zh) * 2010-08-05 2013-05-08 南京海纳医药科技有限公司 西洛多辛的晶型δ、它的制备方法和包含它的药物组合物
WO2012062229A1 (en) 2010-11-12 2012-05-18 Zentiva, K.S. A method of manufacturing (-)-l-(3-hydroxypropyl)-5-[(2r)-2-({2,2,2-trifluoroethoxy)- phenoxyethyl}amino)propyl]-2,3-dihydro-lh-indole-7-carboxamide
CZ2010836A3 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
CZ303061B6 (cs) * 2010-11-12 2012-03-14 Zentiva, K.S. Zpusob výroby (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2,2,2-trifluorethoxy)fenoxyethyl}amino)propyl]-2,3-dihydro-1H-indol-7-karboxamidu
WO2012131710A2 (en) 2011-03-30 2012-10-04 Panacea Biotec Ltd Novel process for the synthesis of indoline derivatives
WO2012147019A1 (en) * 2011-04-26 2012-11-01 Orchid Chemicals And Pharamceuticals Limited An improved process for the preparation of silodosin
WO2012147107A2 (en) * 2011-04-29 2012-11-01 Msn Laboratories Limited Novel & improved processes for the preparation of indoline derivatives and its pharmaceutical composition
CN102382029B (zh) * 2011-07-26 2016-06-29 浙江华海药业股份有限公司 一种西洛多辛中间体成盐制备方法
WO2013072935A2 (en) 2011-10-10 2013-05-23 Cadila Healthcare Limited Process for the preparation of silodosin
IN2014KN01030A (ko) 2011-10-21 2015-10-09 Sandoz Ag
CN102675182B (zh) * 2012-05-24 2014-03-26 临海天宇药业有限公司 1-(3-苯甲酰氧基丙基)-5-(2-羰基丙基)-7-腈基吲哚啉的制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
CN103159664B (zh) * 2013-03-29 2016-03-23 深圳市海滨制药有限公司 一种赛洛多辛原料药及其制备方法、药物组合物
CN104140389A (zh) * 2013-05-06 2014-11-12 昆明积大制药股份有限公司 一种赛洛多辛及其中间体的制备方法
CN103420893B (zh) * 2013-08-02 2015-11-25 江苏和成新材料有限公司 制备西洛多辛中间体的方法
US9643921B2 (en) 2014-02-06 2017-05-09 Ube Industries, Ltd. Method for producing indoline compound
KR20150098565A (ko) * 2014-02-20 2015-08-28 한미정밀화학주식회사 실로도신 제조에 사용되는 신규 중간체, 이의 제조방법 및 이를 이용한 실로도신의 제조방법
KR20150127996A (ko) * 2014-05-08 2015-11-18 한미정밀화학주식회사 실로도신 감마형 결정의 제조방법
JP6242298B2 (ja) * 2014-06-13 2017-12-06 株式会社トクヤマ １−（３−ベンゾイルオキシプロピル）−７−シアノ−５−［（２ｒ）−２−（｛２−［２−（２，２，２−トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］インドリンまたはその塩を製造する方法
KR101628946B1 (ko) * 2014-07-09 2016-06-09 동방에프티엘(주) 실로도신의 개선된 제조방법
KR101725393B1 (ko) * 2014-07-24 2017-04-27 주식회사 경보제약 실로도신의 제조 방법 및 신규 중간체
WO2016042441A1 (en) 2014-09-18 2016-03-24 Mankind Research Centre A novel process for the preparation of considerably pure silodosin
JP2016088847A (ja) * 2014-10-30 2016-05-23 株式会社トクヤマ （‐）‐１‐（３‐ヒドロキシプロピル）‐５‐［［（２ｒ）‐２‐（｛２‐［２‐（２，２，２‐トリフルオロエトキシ）フェノキシ］エチル｝アミノ）プロピル］‐２，３‐ジヒドロ‐１ｈ‐インドール‐７‐カルボキサミド］）の製造方法
CN104478784B (zh) * 2014-11-17 2017-02-22 武汉工程大学 一种西洛多辛草酸盐的晶型及其制备方法
KR101694262B1 (ko) * 2014-12-18 2017-01-10 (주)다산메디켐 실로도신의 결정형의 제조방법
US9356405B1 (en) * 2015-03-05 2016-05-31 Sony Corporation Connector tongue element for an electrical connector plug receptacle and a method for producing the same
BR112018005934A2 (pt) 2015-09-23 2018-10-09 Biocon Ltd formas cristalinas de intermediário de posaconazol e processo para a preparação de posaconazol amorfo
CA2999417A1 (en) * 2015-09-23 2017-03-30 Biocon Limited The process of preparing indoline compounds and a novel indoline salt
ES2607639B1 (es) * 2015-09-30 2018-02-28 Urquima, S.A Sal de ácido maleico de un intermedio de silodosina
CN106995399A (zh) * 2016-01-25 2017-08-01 北京天泰恒华医药技术有限公司 一种制备赛洛多辛的方法
KR102365411B1 (ko) * 2017-08-08 2022-02-21 (주)헥사파마텍 신규의 설폰아마이드 중간체 및 이를 사용한 실로도신의 제조방법
KR102163068B1 (ko) * 2018-07-04 2020-10-07 주식회사 가피바이오 실로도신 합성용 중간체의 제조 방법 및 이를 이용한 실로도신의 제조 방법
CN111217735B (zh) * 2018-11-27 2023-03-14 上海汇伦医药股份有限公司 赛洛多辛中间体的制备方法
WO2020237645A1 (zh) * 2019-05-31 2020-12-03 上海汇伦生命科技有限公司 赛洛多辛中间体的制备方法
CN110452149B (zh) * 2019-06-13 2021-11-02 北京鑫开元医药科技有限公司 二氢吲哚化合物的制备方法、二氢吲哚化合物及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69319551T2 (de) * 1992-12-02 1998-10-29 Kissei Pharmaceutical Indolin Verbindungen zur Behandlung von Dysurien
JP3331047B2 (ja) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 インドリン誘導体
JP2526811B2 (ja) * 1994-07-22 1996-08-21 田辺製薬株式会社 フェネチルアミン誘導体及びその製法
US6310086B1 (en) * 1998-02-27 2001-10-30 Kissei Pharmaceutical Co., Ltd. Indole derivatives and medicinal compositions containing the same
JP4634560B2 (ja) * 2000-01-14 2011-02-16 キッセイ薬品工業株式会社 光学活性なインドリン誘導体の製造方法およびその製造中間体
JP4921646B2 (ja) * 2001-03-08 2012-04-25 キッセイ薬品工業株式会社 １−（３−ベンジルオキシプロピル）−５−（２−置換プロピル）インドリン誘導体およびその使用方法
JP2006188470A (ja) * 2005-01-07 2006-07-20 Kissei Pharmaceut Co Ltd インドリン誘導体およびその製造方法

Also Published As

Publication number Publication date
IL182642A (en) 2012-10-31
TW200621709A (en) 2006-07-01
CA2583660A1 (en) 2006-05-04
KR20070084499A (ko) 2007-08-24
TWI356819B (ko) 2012-01-21
EP1806340A1 (en) 2007-07-11
RU2379289C2 (ru) 2010-01-20
KR101249865B1 (ko) 2013-04-02
ES2362788T3 (es) 2011-07-13
EP1806340A4 (en) 2009-08-12
BRPI0517515A (pt) 2008-10-14
IL182642A0 (en) 2007-07-24
CN101048376A (zh) 2007-10-03
ZA200703996B (en) 2008-09-25
BRPI0517515B1 (pt) 2021-03-09
US7834193B2 (en) 2010-11-16
CN101048376B (zh) 2011-03-23
CA2583660C (en) 2013-02-12
BRPI0517515B8 (pt) 2021-05-25
US20070197627A1 (en) 2007-08-23
JPWO2006046499A1 (ja) 2008-05-22
MX2007005126A (es) 2007-07-04
EP1806340B1 (en) 2011-05-04
ATE508113T1 (de) 2011-05-15
AU2005298078B2 (en) 2011-03-31
JP5049013B2 (ja) 2012-10-17
AU2005298078A1 (en) 2006-05-04
WO2006046499A1 (ja) 2006-05-04
RU2007115888A (ru) 2008-11-10
DE602005027881D1 (de) 2011-06-16

Similar Documents

Publication Publication Date Title
ZA200703996B (en) Indoline compound and process for producing the same
CN1280266C (zh) 酰基苯基脲衍生物,其制备方法和作为药物的用途
JP3034819B2 (ja) １，２−ジフェニルピロール誘導体及び医薬組成物
ES2524916T3 (es) Compuestos heterocíclicos de ácido borónico
JP4171700B2 (ja) 複素環化合物および使用方法
CN1285578C (zh) 取代苯甲酸酰胺及其在抑制血管生成中的应用
JPH08239349A (ja) アリールオキシプロパノールアミンβ３アドレナリン受容体アゴニスト
US20120252864A1 (en) Substituted isoindoline-1,3-dione derivatives
CN1711082A (zh) 新的羟基吲哚类化合物、其作为磷酸二酯酶4抑制剂的应用、以及其制备方法
CN1174956C (zh) 作为IL-1β和TNF-α的抑制剂的氨基二苯酮
JP2012511015A (ja) 癌ならびに免疫および自己免疫疾患の治療のためのアポトーシス誘発剤
CN1893948A (zh) 蕈毒碱性乙酰胆碱受体拮抗剂
CN1139929A (zh) 取代的3-亚芳基-7-氮杂羟吲哚化合物及其制备方法
RU2005108668A (ru) Индолы, обладающие противодиабетической активностью
JP2009511581A (ja) アシルインドール、このような化合物を含む組成物及び使用方法
CN1525955A (zh) 甲酰胺取代的苯基脲衍生物以及用于将其作为药物的制备方法
EP2412706A2 (en) Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
JP2005527492A5 (ko)
CN1491223A (zh) 可用于治疗精神性和神经性疾病的3-二氢吲哚衍生物
CN101058549A (zh) 4－甲氧基－1,3－苯二取代酰胺衍生物
CN1324352A (zh) 2－苯基吡喃－4－酮衍生物
CN1525956A (zh) α-氨基-N-羟基-乙酰胺衍生物
CN101074208A (zh) 吲哚衍生物的制备方法
CN1413215A (zh) 吡唑并哒嗪衍生物的制备方法
JPH11180871A (ja) １，２−ジフェニルピロール誘導体を含有する医薬